RXL

Ultra Health Care

Investment Objective

ProShares Ultra Health Care seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the S&P Health Care Select SectorSM Index.

Documents & Downloads

You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
RXL Market Price 3.48% -15.87% -6.87% -6.87% -19.10% -1.59% 7.28% 8.60% 13.66% 01/30/2007
RXL NAV 3.52% -16.50% -6.92% -6.92% -18.99% -1.59% 7.34% 8.62% 13.66% 01/30/2007

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    RXL
  • Intraday Ticker
    RXL.IV
  • CUSIP
    74347R735
  • Inception Date
    1/30/07
  • Gross Expense Ratio
    1.05%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 7/22/2025
  • NAV
    $39.67
  • NAV Change
    $+1.46 up caret
  • Market Price
    $39.65
  • Market Price Change
    $+1.46 up caret
  • Trading Volume (M)
    13,112
  • 30-Day Median Bid Ask Spread
    0.07%
  • View Premium / Discount
Snapshot
  • Ticker
    RXL
  • Intraday Ticker
    RXL.IV
  • CUSIP
    74347R735
  • Inception Date
    1/30/07
  • Expense Ratio
    0.95%
  • Gross Expense Ratio
    1.05%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 7/22/2025
  • NAV
    $39.67
  • NAV Change
    $+1.46 up caret
  • Market Price
    $39.65
  • Market Price Change
    $+1.46 up caret
  • Trading Volume (M)
    13,112
  • 30-Day Median Bid Ask Spread
    0.07%
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2025. Without the fee waiver performance would likely be lower.

Exposures

Index as of 6/30/2025

Holdings

as of 7/22/2025

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
10.09% LLY ELI LILLY & CO -- $6,442,899.12 8,298 2516152
6.67% JNJ JOHNSON & JOHNSON -- $4,262,063.40 25,380 2475833
5.46% ABBV ABBVIE INC -- $3,486,233.52 18,632 B92SR70
4.27% UNH UNITEDHEALTH GROUP INC -- $2,728,694.10 9,570 2917766
3.61% ABT ABBOTT LABORATORIES -- $2,307,396.96 18,352 2002305
3.38% MRK MERCK & CO. INC. -- $2,161,114.41 26,481 2778844
3.03% ISRG INTUITIVE SURGICAL INC -- $1,932,091.00 3,781 2871301
2.72% AMGN AMGEN INC -- $1,733,873.68 5,672 2023607
2.67% TMO THERMO FISHER SCIENTIFIC INC -- $1,702,782.84 3,982 2886907
2.52% BSX BOSTON SCIENTIFIC CORP -- $1,609,914.96 15,606 2113434
2.36% PFE PFIZER INC -- $1,507,645.80 59,970 2684703
2.26% GILD GILEAD SCIENCES INC -- $1,445,540.57 13,121 2369174
2.24% -- STRYKER CORP -- $1,433,604.20 3,628 2853688
2.00% DHR DANAHER CORP -- $1,276,005.29 6,719 2250870
1.99% VRTX VERTEX PHARMACEUTICALS INC -- $1,273,582.17 2,709 2931034
1.94% MDT MEDTRONIC PLC -- $1,239,841.20 13,528 BTN1Y11
1.61% BMY BRISTOL-MYERS SQUIBB CO -- $1,030,797.32 21,466 2126335
1.47% MCK MCKESSON CORP -- $936,500.40 1,320 2378534
1.32% CI THE CIGNA GROUP -- $845,540.90 2,818 BHJ0775
1.28% CVS CVS HEALTH CORP -- $814,990.44 13,343 2577609
1.11% ZTS ZOETIS INC -- $710,139.43 4,697 B95WG16
1.05% ELV ELEVANCE HEALTH INC -- $671,338.76 2,383 BSPHGL4
1.00% HCA HCA HEALTHCARE INC -- $641,222.19 1,827 B4MGBG6
0.96% REGN REGENERON PHARMACEUTICALS -- $614,218.35 1,095 2730190
0.86% BDX BECTON DICKINSON AND CO -- $548,190.72 3,024 2087807
0.83% COR CENCORA INC -- $533,205.40 1,820 2795393
0.74% EW EDWARDS LIFESCIENCES CORP -- $472,144.40 6,188 2567116
0.71% IDXX IDEXX LABORATORIES INC -- $451,136.00 848 2459202
0.65% RMD RESMED INC -- $413,667.80 1,547 2732903
0.62% CAH CARDINAL HEALTH INC -- $395,420.70 2,517 2175672
0.58% GEHC GE HEALTHCARE TECHNOLOGY -- $369,370.21 4,829 BL6JPG8
0.55% DXCM DEXCOM INC -- $351,971.20 4,135 B0796X4
0.55% A AGILENT TECHNOLOGIES INC -- $349,499.52 3,008 2520153
0.51% IQV IQVIA HOLDINGS INC -- $324,916.92 1,734 BDR73G1
0.46% HUM HUMANA INC -- $294,215.76 1,273 2445063
0.42% MTD METTLER-TOLEDO INTERNATIONAL -- $266,952.24 219 2126249
0.36% STE STERIS PLC -- $231,742.84 1,036 BFY8C75
0.35% LH LABCORP HOLDINGS INC -- $222,325.74 882 BSBK800
0.33% PODD INSULET CORP -- $211,892.94 742 B1XGNW4
0.33% DGX QUEST DIAGNOSTICS INC -- $209,966.72 1,178 2702791
0.32% ZBH ZIMMER BIOMET HOLDINGS INC -- $201,437.24 2,087 2783815
0.31% BIIB BIOGEN INC -- $197,656.10 1,546 2455965
0.28% WAT WATERS CORP -- $180,524.88 628 2937689
0.26% WST WEST PHARMACEUTICAL SERVICES -- $165,926.20 758 2950482
0.24% COO COOPER COS INC/THE -- $154,093.30 2,110 BQPDXR3
0.24% HOLX HOLOGIC INC -- $153,684.87 2,351 2433530
0.23% BAX BAXTER INTERNATIONAL INC -- $148,966.65 5,415 2085102
0.23% CNC CENTENE CORP -- $146,394.61 5,249 2807061
0.22% ALGN ALIGN TECHNOLOGY INC -- $139,335.08 718 2679204
0.19% -- REVVITY INC -- $119,489.59 1,243 2305844
0.18% MRNA MODERNA INC -- $117,500.70 3,590 BGSXTS3
0.18% INCY INCYTE CORP -- $116,785.50 1,695 2471950
0.18% VTRS VIATRIS INC -- $114,391.20 12,380 BMWS3X9
0.17% SOLV SOLVENTUM CORP -- $106,463.20 1,460 BMTQB43
0.16% MOH MOLINA HEALTHCARE INC -- $103,326.08 572 2212706
0.15% UHS UNIVERSAL HEALTH SERVICES-B -- $98,096.04 603 2923785
0.15% HSIC HENRY SCHEIN INC -- $92,704.80 1,284 2416962
0.14% TECH BIO-TECHNE CORP -- $87,807.36 1,653 BSHZ3Q0
0.13% CRL CHARLES RIVER LABORATORIES -- $84,620.48 518 2604336
0.10% DVA DAVITA INC -- $63,969.90 438 2898087
31.38% -- HEALTH CARE SELECT SECTOR INDEX SWAP UBS AG 20,040,138 -- 14,855 --
22.56% -- HEALTH CARE SELECT SECTOR INDEX SWAP BANK OF AMERICA NA 14,407,854 -- 10,680 --
22.30% -- HEALTH CARE SELECT SECTOR INDEX SWAP GOLDMAN SACHS INTERNATIONAL 14,241,921 -- 10,557 --
16.01% -- HEALTH CARE SELECT SECTOR INDEX SWAP CITIBANK NA 10,225,799 -- 7,580 --
14.07% -- HEALTH CARE SELECT SECTOR INDEX SWAP SOCIETE GENERALE 8,987,371 -- 6,662 --
13.84% -- HEALTH CARE SELECT SECTOR INDEX SWAP BNP PARIBAS 8,839,515 -- 6,552 --
-- -- NET OTHER ASSETS (LIABILITIES) -- $12,814,091.14 12,814,091 --

Index

as of 6/30/2025

  • Total Number of Companies60
  • Price/Earnings Ratio17.56
  • Price/Book Ratio4.58
  • Dividend Yield ( % )1.85
  • Avg. Index Market Capitalization$84.88 billion
About the Index

The S&P Health Care Select Sector Index is designed to measure the performance of health care companies included in the S&P 500 Index.

The Index includes health care companies in the following industries according to the Global Industry Classification Standard (GICS): health care equipment & supplies, health care providers & services; health care technology; biotechnology; pharmaceuticals; and life sciences tools & services.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.